Stock IVX INVION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Invion Limited

Equities

IVX

AU000000IVX4

Market Closed - Australian S.E.
Other stock markets
 02:10:23 2024-05-29 am EDT 		5-day change 1st Jan Change
0.005 AUD +25.00% Intraday chart for Invion Limited 0.00% 0.00%
May. 08 Invion Partners with Hanlim Pharma for Glioblastoma Treatment MT
Mar. 05 Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Invion Partners with Hanlim Pharma for Glioblastoma Treatment
MT
Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results
MT
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Invion Signs Collaboration Agreement with Dr. I&B Co for HPV Treatment; Shares Up 25%
MT
Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production
MT
Invion Grants RMW Cho Group Right to Distribute Cancer Treatment Products in South Korea
MT
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Invion Launches New Interactive Investor Hub
MT
Invion Limited agreed to acquire Next Generation Photodynamic Therapy of RMW Cho Group Limited.
CI
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2022
CI
Invion Expanding Photosoft Technology Rights to US, Canada, Hong Kong
MT
Invion Limited Announces Vitro Test Results on Photosoft
CI
Invion Limited Announces the Positive Screening Results from in Vitro Studies of PhotosoftTM on the Inhibition of the Dengue Virus
CI
Invion Validates Efficacy of Photodynamic Drug Against Anal Cancer
MT
Invion Limited Announces INV043 Effective Against Anal Cancer Squamous Cell Carcinomas in Vitro
CI
Invion Limited Announces PhotosoftTM Shows Activity Against Zika Virus in Preliminary Assays
CI
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
Invion : Activities Report and Appendix 4C
PU
Invion : Notification regarding unquoted securities - IVX
PU
Invion's Cancer Treatment Patent Application Published
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IVX Stock
  4. News Invion Limited